2m 2m 2m 2m 2m 2m 2m
PHARMACYTE BIOT (PMCB)
NASDAQ
$0.79+$0.02 (+2.28%)
Price as of Jun 23, 2026 4:14 PM EDT- $8.2MMarket Cap
- -27.54%1-Year Change
- BiotechnologyIndustry
PHARMACYTE BIOT (PMCB)
$0.79+$0.02 (+2.28%)
PMCB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.78 | ||
Change | +$0.008 (+1.07%) | ||
Open | $0.76 | ||
High | $0.80 | ||
Low | $0.76 | ||
Previous Close | $0.77 | ||
Volume | 78,219 | ||
30-Day Average Volume | 140,929 | ||
1-Week Change | -6.24% | ||
1-Month Change | -4.16% | ||
1-Year Change | -26.76% | ||
3-Year Change | -73.86% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 10.7M | ||
Total Assets | $55.9M | ||
Market Cap | $8.2M | ||
Enterprise Value | -$11.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$1.6M | ||
Free Cash Flow | -$786,848.00 | ||
EBIT | -$1.6M | ||
EBITDA | -$1.6M | ||
Net Working Capital | $19.0M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | 8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 1500 | ||
Last Split Date | 07/12/2021 | ||